DuoTrav® Eye Drops As Replacement Therapy Program

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00828906

Enrollment

128

Registered

2009-01-26

Start date

2009-02-28

Completion date

Unknown

Last updated

2012-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open-angle Glaucoma, Ocular Hypertension

Keywords

Glaucoma, IOP, DuoTrav

Brief summary

To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG) or ocular hypertension (OH).

Interventions

DRUGDuoTrav

DuoTrav Eye Drops

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with OAG or OH for whom single agent therapy provides insufficient intraocular pressure reduction

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
Intra Ocular Pressure	visit 1, Visits 2-3, Visits 6-8

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026